Precision oncology has made huge strides in recent years. Thanks to advancements in technology, bioinformatics and computer modeling, many providers are now able to incorporate precision oncology into their day-to-day practice, ensuring patients receive precise diagnoses and are then connected to the right treatment or clinical trial. 

But roadblocks remain. Health equity is a major concern, both because limited data could exacerbate health disparities and because many patients cannot afford care. Additionally, a large pool of patients is needed to ensure comprehensive data, and some payers still need to be convinced of precision oncology's value. 

During a Becker's advisory call, leaders from hospitals and health systems across the country discussed these challenges and how the field will continue to evolve, offering insights on how organizations of any size can find success utilizing precision oncology for treatment. 

Download the white paper to learn: